Clinical Trial: Evaluate the Effect of Orelabrutinib on Cardiac Repolarization in Healthy Subjects
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Condition: Healthy Subject
Study Type: Interventional
Official Title: A Randomized, Blinded, Placebo- and Positive-Controlled, Four-Period, Crossover-Design Thorough QT/QTc (TQT) Study to Evaluate the Effect of Orelabrutinib on Cardiac Repolarization in Healthy Subjects
Brief Summary:
This is A Randomized, Blinded, Placebo- and Positive-Controlled, Four-Period, Crossover-Design Thorough QT/QTc (TQT) Study to Evaluate the Effect of Orelabrutinib on Cardiac Repolarization in Healthy Subjects
Read more